We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$15.6M
Cap. Flow
+$5.76M
Cap. Flow %
5.56%
Top 10 Hldgs %
71.2%
Holding
45
New
12
Increased
6
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
TWM icon
ProShares UltraShort Russell2000
TWM
+$9.12M
2
AGN
Allergan plc
AGN
+$6.71M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$4.53M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$2.66M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.04M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$4.86M
2
MRK icon
Merck
MRK
+$4.53M
3
SNY icon
Sanofi
SNY
+$3.07M
4
AZN icon
AstraZeneca
AZN
+$1.83M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.59M

Sector Composition

Rank Sector Weight
1 Healthcare 53.84%
2 Miscellaneous 46.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIN
26
DELISTED
Kindred Biosciences, Inc.
KIN
$463K 0.45%
50,000
– –
FCSC
27
DELISTED
Fibrocell Science Inc.
FCSC
$458K 0.44%
10,518
– –
SCMP
28
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$336K 0.32%
51,630
-45,000
-47% -$299K
IMNN icon
29
Imunon
IMNN
$8.98M
$296K 0.29%
37
– –
STML
30
DELISTED
Stemline Therapeutics, Inc.
STML
$205K 0.2%
16,464
– –
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$179K 0.17%
+119
New +$172K
ZGNX
32
DELISTED
Zogenix, Inc.
ZGNX
$173K 0.17%
18,750
-12,500
-40% -$142K
BIS icon
33
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
– –
-5,000
Closed -$2.85M
CYTK icon
34
Cytokinetics
CYTK
$10.8B
– –
-41,666
Closed -$199K
GLMD icon
35
Galmed Pharmaceuticals
GLMD
$4.49M
– –
-35
Closed -$487K
IWM icon
36
PUT
iShares Russell 2000 ETF
IWM
$81.9B
– –
-100,000
Closed -$11.9M
MRK icon
37
Merck
MRK
$369B
– –
-80,696
Closed -$4.53M
SNY icon
38
Sanofi
SNY
$107B
– –
-57,735
Closed -$3.07M
SPY icon
39
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
– –
-100,000
Closed -$19.6M
SUPN icon
40
CALL
Supernus Pharmaceuticals
SUPN
$2.57B
– –
-200,000
Closed -$2.19M
TWM icon
41
CALL
ProShares UltraShort Russell2000
TWM
$43.9M
– –
-15,000
Closed -$12.9M
VXRT
42
DELISTED
Vaxart
VXRT
– –
-13,228
Closed -$415K
IPXL
43
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-50,000
Closed -$1.5M
AMRI
44
CALL
DELISTED
Albany Molecular Research Inc
AMRI
– –
-100,000
Closed -$2.01M
AUXL
45
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-229,481
Closed -$4.86M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Healthcare Value Capital held 45 positions worth $104M, down 13% from $119M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Healthcare Value Capital deployed $5.76M of net new capital in Q3 2014, opening 12 new positions and adding to 6 existing holdings. Its largest new stake was Allergan plc: 30,000 shares worth $7.24M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 47% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was AstraZeneca, an estimated $1.83M trimmed.

  • Healthcare Value Capital's largest Q3 2014 buy was Allergan plc: 30,000 shares worth $7.24M.
  • Healthcare Value Capital added most to ProShares UltraShort Russell2000 in Q3 2014, an estimated $9.12M increase.
  • Healthcare Value Capital's biggest Q3 2014 reduction was AstraZeneca, cutting an estimated $1.83M.
  • Healthcare Value Capital fully exited AUXILIUM PHARAMCEUTICALS INC in Q3 2014, selling an estimated $4.86M.
  • Healthcare Value Capital's ten largest holdings make up 71% of its $104M portfolio in Q3 2014.
  • Healthcare Value Capital opened 12 new positions and closed 13 in Q3 2014.
  • Healthcare Value Capital's portfolio value fell 13% quarter-over-quarter to $104M.

Based on Healthcare Value Capital's 13F filing for Q3 2014, filed 13 Nov 2014.